Form 4: Stereotaxis Director Menawat Receives Restricted Share Units
SEC Form 4 Filing
Director Arun Swarup Menawat of Stereotaxis, Inc. was granted 53,475 restricted share units on July 1, 2024.
Summary
- On July 1, 2024, Arun Swarup Menawat, a director of Stereotaxis, Inc., received a grant of 53,475 restricted share units.
- Each restricted share unit represents the right to receive one share of Stereotaxis common stock.
- These restricted share units vest on the earliest of (i) the fifth anniversary of the award date, (ii) the termination of the director's service on the board, or (iii) a Change of Control event.
- Following this transaction, Menawat beneficially owns 845,344 shares of Stereotaxis common stock.
Sentiment
Score: 7
Explanation: The sentiment is neutral to slightly positive as it reflects standard executive compensation practices, aligning director interests with shareholders.
Positives
- The grant of restricted share units aligns the director's interests with those of the shareholders, incentivizing long-term value creation.
Future Outlook
The vesting of the restricted share units is contingent upon future events, including continued service on the board or a change of control.
Industry Context
This type of equity compensation is common for directors of publicly traded companies to align their interests with shareholders.
Stakeholder Impact
- Shareholders may view the grant of restricted share units positively as it aligns the director's interests with the company's long-term success.
Key Dates
| Date | Description |
|---|---|
| 07/01/2024 | Date of the transaction: Grant of restricted share units to Arun Swarup Menawat. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.